A Pilot Study Evaluating Serum MMP7 as a Preoperative Prognostic Marker for Pancreatic Ductal Adenocarcinoma Patients

Wang Sam C.; Parekh Justin R.; Porembka Matthew R.; Nathan Hari; DAngelica Michael I.; DeMatteo Ronald P.; Fong Yuman; Kingham T. Peter; Jarnagin William R.; Allen Peter J.

首页> 外文期刊>Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract >A Pilot Study Evaluating Serum MMP7 as a Preoperative Prognostic Marker for Pancreatic Ductal Adenocarcinoma Patients

【24h】

A Pilot Study Evaluating Serum MMP7 as a Preoperative Prognostic Marker for Pancreatic Ductal Adenocarcinoma Patients

机译：评估血清MMP7作为胰腺导管腺癌患者术前预后标志物的一项初步研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Current preoperative risk stratification modalities for pancreatic ductal adenocarcinoma (PDA) patients are inadequate. Elevated serum matrix metalloproteinase 7 (MMP7) is associated with metastatic PDA. We evaluated preoperative MMP7 level as a prognostic marker in patients with resectable PDA.

机译：对于胰腺导管腺癌（PDA）患者，当前的术前危险分层方法尚不完善。升高的血清基质金属蛋白酶7（MMP7）与转移性PDA相关。我们评估术前MMP7水平作为可切除PDA患者的预后指标。

著录项

来源
《Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract》 |2016年第5期|共6页
作者
Wang Sam C.; Parekh Justin R.; Porembka Matthew R.; Nathan Hari; DAngelica Michael I.; DeMatteo Ronald P.; Fong Yuman; Kingham T. Peter; Jarnagin William R.; Allen Peter J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词
Pancreas cancer; MMP7; CA19-9; Biomarker;

机译：胰腺癌;MMP7;CA19-9;生物标志物;

相似文献

外文文献
中文文献
专利

1. A Pilot Study Evaluating Serum MMP7 as a Preoperative Prognostic Marker for Pancreatic Ductal Adenocarcinoma Patients [J] . Wang Sam C., Parekh Justin R., Porembka Matthew R., Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract . 2016,第5期

机译：评估血清MMP7作为胰腺导管腺癌患者术前预后标志物的一项初步研究
2. Serum Marker Score Based on Prognostic Nutrition Index, Carcinoembryonic Antigen, and Carbohydrate Antigen 19-9 Is Associated With Recurrence for Patients Undergoing Surgery for Pancreatic Ductal Adenocarcinoma [J] . Nakagawa Shigeki, Yamashita Yo-ichi, Umezaki Naoki, Pancreas . 2018,第9期

机译：基于预后营养指数，癌丙烯醛抗原和碳水化合物抗原19-9的血清标记分数与接受胰腺导管腺癌手术的患者的复发相关
3. Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma [J] . Wataru lzumo, Ryota Higuchi, Toru Furukawa, Scandinavian journal of gastroenterology. . 2019,第1a12期

机译：可重型胰腺导管腺癌患者术前预测因子的评价
4. Texture Analysis For Survival Prediction of Pancreatic Ductal Adenocarcinoma Patients with Neoadjuvant Chemotherapy [C] . Jayasree Chakraborty, Liana Langdon-Embry, Joanna G. Escalon, Conference on imaging processing . 2016

机译：纹理分析对胰腺癌新辅助化疗患者生存率的预测
5. The CA19-9 Antigen and sTRA Glycans Define Independent Pancreatic Ductal Adenocarcinoma Subpopulations Improving Diagnostic Accuracy and Approach to Prognostic Classification [D] . Barnett, Daniel Mark. 2020

机译：Ca19-9抗原和stra聚糖定义独立的胰腺导管腺癌群，提高了预后分类的诊断准确性和方法
6. A Pilot Study Evaluating Serum MMP7 as a Preoperative PrognosticMarker for Pancreatic Ductal Adenocarcinoma Patients [O] . Sam C. Wang, Justin R. Parekh, Matthew R. Porembka, -1

机译：评估血清MMP7作为术前预后的初步研究胰腺导管腺癌患者的标志物
7. A Pilot Study Evaluating Serum MMP7 as a Preoperative Prognostic Marker for Pancreatic Ductal Adenocarcinoma Patients [O] . Sam C. Wang, Justin R. Parekh, Matthew R. Porembka, 2016

机译：评估血清MMP7作为胰腺导管腺癌患者术前预后标志物的试验研究

A Pilot Study Evaluating Serum MMP7 as a Preoperative Prognostic Marker for Pancreatic Ductal Adenocarcinoma Patients

摘要

著录项

相似文献

相关主题

期刊订阅